Sale!

ADAMTSL2 Gene Geleophysic dysplasia type 1 Genetic Test

Name: ADAMTSL2 Gene Geleophysic dysplasia type 1 Genetic Test
SKU: TEST-2998
Price: 4400 AED
Availability: InStock

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The ADAMTSL2 Gene Geleophysic Dysplasia Type 1 Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE. This test is designed to identify mutations in the ADAMTSL2 gene, which are responsible for Geleophysic Dysplasia Type 1, a rare genetic disorder characterized by short stature, short hands and feet, and distinctive facial features. The condition can also affect the heart, bones, and other organs, making early diagnosis crucial for managing symptoms and improving the quality of life for those affected.

DNA Labs UAE employs advanced genetic testing techniques to accurately analyze the ADAMTSL2 gene, ensuring reliable results for patients and their families. The test is priced at 4400 AED, reflecting the sophisticated technology and expertise required to conduct this complex analysis. By opting for this test, individuals can gain vital insights into their genetic makeup, enabling informed decisions about their health and future.

Description

ADAMTSL2 Gene Geleophysic dysplasia type 1 Genetic Test

Test Name: ADAMTSL2 Gene Geleophysic dysplasia type 1 Genetic Test

Components: Blood Sample

Price: 4400.0 AED

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test Type: Osteology Dermatology Immunology Disorders

Doctor: Dermatologist

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for ADAMTSL2 Gene Geleophysic dysplasia type 1 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with ADAMTSL2 Gene Geleophysic dysplasia type 1 NGS Genetic DNA Test gene ADAMTSL2

Test Details:

The ADAMTSL2 gene is associated with a rare genetic disorder called Geleophysic dysplasia type 1. Geleophysic dysplasia is a group of genetic disorders characterized by short stature, unique facial features, joint stiffness, and other skeletal abnormalities.

NGS (Next-Generation Sequencing) genetic testing is a method used to analyze multiple genes simultaneously. It allows for the rapid and efficient sequencing of a large number of genes, making it a useful tool for diagnosing genetic disorders like Geleophysic dysplasia type 1.

By analyzing the ADAMTSL2 gene through NGS genetic testing, healthcare professionals can identify any mutations or variations in the gene that may be causing the disorder. This information can help with accurate diagnosis, genetic counseling, and potentially guide treatment options for affected individuals and their families.

Test Name	ADAMTSL2 Gene Geleophysic dysplasia type 1 Genetic Test
Components
Price	4400.0 AED
Sample Condition	Blood
Report Delivery	3 to 4 Weeks
Method	NGS Technology
Test type	Osteology Dermatology Immunology Disorders
Doctor	Dermatologist
Test Department:	Genetics
Pre Test Information	Clinical History of Patient who is going for ADAMTSL2 Gene Geleophysic dysplasia type 1 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with ADAMTSL2 Gene Geleophysic dysplasia type 1 NGS Genetic DNA Test gene ADAMTSL2
Test Details	The ADAMTSL2 gene is associated with a rare genetic disorder called Geleophysic dysplasia type 1. Geleophysic dysplasia is a group of genetic disorders characterized by short stature, unique facial features, joint stiffness, and other skeletal abnormalities. NGS (Next-Generation Sequencing) genetic testing is a method used to analyze multiple genes simultaneously. It allows for the rapid and efficient sequencing of a large number of genes, making it a useful tool for diagnosing genetic disorders like Geleophysic dysplasia type 1. By analyzing the ADAMTSL2 gene through NGS genetic testing, healthcare professionals can identify any mutations or variations in the gene that may be causing the disorder. This information can help with accurate diagnosis, genetic counseling, and potentially guide treatment options for affected individuals and their families.